المؤلفون: Evelien Moorkens, Brian Godman, Isabelle Huys, Iris Hoxha, Admir Malaj, Simon Keuerleber, Silvia Stockinger, Sarah Mörtenhuber, Maria Dimitrova, Konstantin Tachkov, Luka Vončina, Vera Vlahović Palčevski, Gnosia Achniotou, Juraj Slabý, Leona Popelková, Kateřina Kohoutová, Dorthe Bartels, Ott Laius, Jaana E. Martikainen, Gisbert W. Selke, Vasileios Kourafalos, Einar Magnússon, Rannveig Einarsdóttir, Roisín Adams, Roberta Joppi, Eleonora Allocati, Arianit Jakupi, Anita Viksna, Ieva Greičiūtė-Kuprijanov, Patricia Vella Bonanno, Vincent Suttorp, Øyvind Melien, Robert Plisko, Ileana Mardare, Dmitry Meshkov, Tanja Novakovic, Jurij Fürst, Corinne Zara, Vanda Marković-Peković, Nataša Grubiša, Gustaf Befrits, Robert Puckett, Arnold G. Vulto

المصدر: Frontiers in Pharmacology, Vol 11 (2021)

مصطلحات موضوعية: adalimumab, prices, biosimilars, Europe, Humira, competition, Therapeutics. Pharmacology, RM1-950

وصف الملف: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fphar.2020.591134/full; https://doaj.org/toc/1663-9812

URL الوصول: https://doaj.org/article/91efa0738a404ac58954a5cf23bc3c10

المؤلفون: Brian Godman, Magdalene Wladysiuk, Stuart McTaggart, Amanj Kurdi, Eleonora Allocati, Mihajlo Jakovljevic, Francis Kalemeera, Iris Hoxha, Anna Nachtnebel, Robert Sauermann, Manfred Hinteregger, Vanda Marković-Peković, Biljana Tubic, Guenka Petrova, Konstantin Tachkov, Juraj Slabý, Radka Nejezchlebova, Iva Selke Krulichová, Ott Laius, Gisbert Selke, Irene Langner, András Harsanyi, András Inotai, Arianit Jakupi, Svens Henkuzens, Kristina Garuolienė, Jolanta Gulbinovič, Patricia Vella Bonanno, Jakub Rutkowski, Skule Ingeberg, Øyvind Melien, Ileana Mardare, Jurij Fürst, Sean MacBride-Stewart, Carol Holmes, Caridad Pontes, Corinne Zara, Marta Turu Pedrola, Mikael Hoffmann, Vasileios Kourafalos, Alice Pisana, Rita Banzi, Stephen Campbell, Bjorn Wettermark

المصدر: BioMed Research International, Vol 2021 (2021)

مصطلحات موضوعية: Medicine

Relation: http://dx.doi.org/10.1155/2021/9996193; https://doaj.org/toc/2314-6133; https://doaj.org/toc/2314-6141; https://doaj.org/article/81a668c4be124d56b4af2ff30f7a89cd

الاتاحة: https://doi.org/10.1155/2021/9996193
https://doaj.org/article/81a668c4be124d56b4af2ff30f7a89cd

المؤلفون: Brian Godman, Magdalene Wladysiuk, Stuart McTaggart, Amanj Kurdi, Eleonora Allocati, Mihajlo Jakovljevic, Francis Kalemeera, Iris Hoxha, Anna Nachtnebel, Robert Sauermann, Manfred Hinteregger, Vanda Marković-Peković, Biljana Tubic, Guenka Petrova, Konstantin Tachkov, Juraj Slabý, Radka Nejezchlebova, Iva Selke Krulichová, Ott Laius, Gisbert Selke, Irene Langner, András Harsanyi, András Inotai, Arianit Jakupi, Svens Henkuzens, Kristina Garuolienė, Jolanta Gulbinovič, Patricia Vella Bonanno, Jakub Rutkowski, Skule Ingeberg, Øyvind Melien, Ileana Mardare, Jurij Fürst, Sean MacBride-Stewart, Carol Holmes, Caridad Pontes, Corinne Zara, Marta Turu Pedrola, Mikael Hoffmann, Vasileios Kourafalos, Alice Pisana, Rita Banzi, Stephen Campbell, Bjorn Wettermark

المصدر: BioMed Research International. 2023:1-3

مصطلحات موضوعية: General Immunology and Microbiology, General Medicine, General Biochemistry, Genetics and Molecular Biology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::b67ceb61bf776c1d25d840ba91780b63
https://doi.org/10.1155/2023/9757348

المؤلفون: Alpha Diallo, Marius Trøseid, Victoria Charlotte Simensen, Anaïs Boston, Jacques Demotes, Inge Christoffer Olsen, Florence Chung, José Artur Paiva, Maya Hites, Florence Ader, Jose Ramon Arribas, Andreas Baratt-Due, Øyvind Melien, Evelina Tacconelli, Thèrèse Staub, Richard Greil, Sotirios Tsiodras, Matthias Briel, Hélène Esperou, France Mentré, Joe Eustace, Juliette Saillard, Christelle Delmas, Soizic LeMestre, Marina Dumousseaux, Dominique Costagliola, John-Arne Røttingen, Yazdan Yazdanpanah

المساهمون: Agence Nationale de Recherches sur le Sida et les Hépatites Virales (ANRS), Institut National de la Santé et de la Recherche Médicale (INSERM), Oslo University Hospital [Oslo], European Clinical Research Infrastructures Network [Dusseldorf] (ECRIN), Hospital de São João [Porto], Université libre de Bruxelles (ULB), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon, Centre International de Recherche en Infectiologie (CIRI), École normale supérieure de Lyon (ENS de Lyon)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Université Jean Monnet - Saint-Étienne (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), La Paz University Hospital, Norwegian Institute of Public Health [Oslo] (NIPH), Università degli studi di Verona = University of Verona (UNIVR), Centre Hospitalier de Luxembourg [Luxembourg] (CHL), Paracelsus Medizinische Privatuniversität = Paracelsus Medical University (PMU), National and Kapodistrian University of Athens (NKUA), University Hospital Basel [Basel], Pôle de Recherche Clinique [Paris] (PRC), AP-HP - Hôpital Bichat - Claude Bernard [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), University College Cork (UCC), Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), CIC - CHU Bichat, Infection, Anti-microbiens, Modélisation, Evolution (IAME (UMR_S_1137 / U1137)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)-Université Sorbonne Paris Nord

المصدر: Clinical Microbiology and Infection
Clinical Microbiology and Infection, 2022, 28 (1), pp.1--5. ⟨10.1016/j.cmi.2021.10.011⟩

مصطلحات موضوعية: Microbiology (medical), Medical education, Coronavirus disease 2019 (COVID-19), Adaptive Clinical Trials as Topic, EU-RESPOSE, Financial hurdles, Legal hurdles, Platform trials, Regulatory hurdles, MEDLINE, COVID-19, Context (language use), General Medicine, Clinical trial, Infectious Diseases, Political science, Pandemic, Commentary, Government Regulation, Humans, European Union, Pandemics, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5319b58a626dbe39a3a5b25090dd550d
https://doi.org/10.1016/j.cmi.2021.10.011

المؤلفون: Brian Godman, Anna Bucsics, Patricia Vella Bonanno, Wija Oortwijn, Celia C. Rothe, Alessandra Ferrario, Simone Bosselli, Andrew Hill, Antony P. Martin, Steven Simoens, Amanj Kurdi, Mohamed Gad, Jolanta Gulbinovič, Angela Timoney, Tomasz Bochenek, Ahmed Salem, Iris Hoxha, Robert Sauermann, Amos Massele, Augusto Alfonso Guerra, Guenka Petrova, Zornitsa Mitkova, Gnosia Achniotou, Ott Laius, Catherine Sermet, Gisbert Selke, Vasileios Kourafalos, John Yfantopoulos, Einar Magnusson, Roberta Joppi, Margaret Oluka, Hye-Young Kwon, Arianit Jakupi, Francis Kalemeera, Joseph O. Fadare, Oyvind Melien, Maciej Pomorski, Magdalene Wladysiuk, Vanda Marković-Peković, Ileana Mardare, Dmitry Meshkov, Tanja Novakovic, Jurij Fürst, Dominik Tomek, Corrine Zara, Eduardo Diogene, Johanna C. Meyer, Rickard Malmström, Björn Wettermark, Zinhle Matsebula, Stephen Campbell, Alan Haycox

المصدر: Frontiers in Public Health, Vol 6 (2018)

مصطلحات موضوعية: managed entry, health policy, pharmaceuticals, financing, cancer, orphan diseases, Public aspects of medicine, RA1-1270

Relation: https://www.frontiersin.org/article/10.3389/fpubh.2018.00328/full; https://doaj.org/toc/2296-2565; https://doaj.org/article/44e09c6a8ab54400ba7f5f970ab42861

الاتاحة: https://doi.org/10.3389/fpubh.2018.00328
https://doaj.org/article/44e09c6a8ab54400ba7f5f970ab42861

المؤلفون: Patricia Vella Bonanno, Michael Ermisch, Brian Godman, Antony P. Martin, Jesper Van Den Bergh, Liudmila Bezmelnitsyna, Anna Bucsics, Francis Arickx, Alexander Bybau, Tomasz Bochenek, Marc van de Casteele, Eduardo Diogene, Irene Eriksson, Jurij Fürst, Mohamed Gad, Ieva Greičiūtė-Kuprijanov, Martin van der Graaff, Jolanta Gulbinovic, Jan Jones, Roberta Joppi, Marija Kalaba, Ott Laius, Irene Langner, Ileana Mardare, Vanda Markovic-Pekovic, Einar Magnusson, Oyvind Melien, Dmitry O. Meshkov, Guenka I. Petrova, Gisbert Selke, Catherine Sermet, Steven Simoens, Ad Schuurman, Ricardo Ramos, Jorge Rodrigues, Corinne Zara, Eva Zebedin-Brandl, Alan Haycox

المصدر: Frontiers in Pharmacology, Vol 8 (2017)

مصطلحات موضوعية: European Medicines Agency, Adaptive Pathways, Health Technology Assessment, marketing authorization, payers, Therapeutics. Pharmacology, RM1-950

Relation: http://journal.frontiersin.org/article/10.3389/fphar.2017.00497/full; https://doaj.org/toc/1663-9812; https://doaj.org/article/f04463fb5300454ea10bcc289ffc51ff

الاتاحة: https://doi.org/10.3389/fphar.2017.00497
https://doaj.org/article/f04463fb5300454ea10bcc289ffc51ff

المؤلفون: Mikael Hoffmann, Stuart McTaggart, Vanda Marković-Peković, Irene Langner, Skule Ingeberg, Iva Selke Krulichová, Carol Holmes, Juraj Slabý, Brian Godman, Biljana Tubić, Svens Henkuzens, Corinne Zara, Jakub Rutkowski, Jurij Fürst, András Inotai, Stephen Campbell, Konstantin Tachkov, Sean MacBride-Stewart, Ileana Mardare, Mihajlo Jakovljevic, Kristina Garuolienė, Marta Turu Pedrola, Øyvind Melien, Gisbert Selke, Magdalene Wladysiuk, Björn Wettermark, Amanj Kurdi, Arianit Jakupi, Caridad Pontes, Vasileios Kourafalos, Manfred Hinteregger, Eleonora Allocati, Radka Nejezchlebova, Guenka Petrova, Francis Kalemeera, Rita Banzi, András Harsányi, Patricia Vella Bonanno, Ott Laius, Robert Sauermann, Alice Pisana, Jolanta Gulbinovič, Anna Nachtnebel, Iris Hoxha

المصدر: BioMed research international, London : Hindawi Ltd., 2021, vol. 2021, art. no. 9996193, p. [1-16]
BioMed Research International
BioMed Research International, Vol 2021 (2021)

مصطلحات موضوعية: Hälso- och sjukvårdsorganisation, hälsopolitik och hälsoekonomi, Article Subject, Long acting insulin, Cost-Benefit Analysis, Health authority, medicine.medical_treatment, Pharmaceutical policy, Insulin Glargine, Genetics and Molecular Biology, General Biochemistry, Genetics and Molecular Biology, Patient Education as Topic, Systematic reviews (Medical research), Diabetes Mellitus, medicine, Humans, Hypoglycemic Agents, Poor glycaemic control, Drugs -- Costs, Biosimilar Pharmaceuticals, General Immunology and Microbiology, Public economics, Insulin glargine, Insulin, Stakeholder, Biosimilar, Health Care Service and Management, Health Policy and Services and Health Economy, General Medicine, Europe, Insulin, Long-Acting, Eastern european, Diabetes -- Patients -- Europe, General Biochemistry, Medicine, Business, Research Article, medicine.drug

وصف الملف: application/pdf; text/xhtml

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1f71eb049d04b088f4f63846e1ca06c
https://repository.vu.lt/VU:ELABAPDB116509835&prefLang=en_US

المؤلفون: Alice Pisana, Björn Wettermark, Amanj Kurdi, Biljana Tubic, Caridad Pontes, Corinne Zara, Eric Van Ganse, Guenka Petrova, Ileana Mardare, Jurij Fürst, Marta Roig-Izquierdo, Oyvind Melien, Patricia Vella Bonanno, Rita Banzi, Vanda Marković-Peković, Zornitsa Mitkova, Brian Godman

مصطلحات موضوعية: Pharmacology, Basic Pharmacology, Clinical Pharmacology and Therapeutics, Clinical Pharmacy and Pharmacy Practice, Pharmaceutical Sciences, Pharmacogenomics, Toxicology (incl. Clinical Toxicology), Pharmacology and Pharmaceutical Sciences not elsewhere classified, new cancer medicines, patient-level datasets, pricing and reimbursement, funding concerns, pharmaceutical policy, cross-national collaboration, european countries

Relation: https://figshare.com/articles/dataset/Table2_Challenges_and_Opportunities_With_Routinely_Collected_Data_on_the_Utilization_of_Cancer_Medicines_Perspectives_From_Health_Authority_Personnel_Across_18_European_Countries_docx/20077697

الاتاحة: https://doi.org/10.3389/fphar.2022.873556.s003
https://figshare.com/articles/dataset/Table2_Challenges_and_Opportunities_With_Routinely_Collected_Data_on_the_Utilization_of_Cancer_Medicines_Perspectives_From_Health_Authority_Personnel_Across_18_European_Countries_docx/20077697

المؤلفون: Alice Pisana, Björn Wettermark, Amanj Kurdi, Biljana Tubic, Caridad Pontes, Corinne Zara, Eric Van Ganse, Guenka Petrova, Ileana Mardare, Jurij Fürst, Marta Roig-Izquierdo, Oyvind Melien, Patricia Vella Bonanno, Rita Banzi, Vanda Marković-Peković, Zornitsa Mitkova, Brian Godman

مصطلحات موضوعية: Pharmacology, Basic Pharmacology, Clinical Pharmacology and Therapeutics, Clinical Pharmacy and Pharmacy Practice, Pharmaceutical Sciences, Pharmacogenomics, Toxicology (incl. Clinical Toxicology), Pharmacology and Pharmaceutical Sciences not elsewhere classified, new cancer medicines, patient-level datasets, pricing and reimbursement, funding concerns, pharmaceutical policy, cross-national collaboration, european countries

Relation: https://figshare.com/articles/dataset/DataSheet1_Challenges_and_Opportunities_With_Routinely_Collected_Data_on_the_Utilization_of_Cancer_Medicines_Perspectives_From_Health_Authority_Personnel_Across_18_European_Countries_pdf/20077691

الاتاحة: https://doi.org/10.3389/fphar.2022.873556.s001
https://figshare.com/articles/dataset/DataSheet1_Challenges_and_Opportunities_With_Routinely_Collected_Data_on_the_Utilization_of_Cancer_Medicines_Perspectives_From_Health_Authority_Personnel_Across_18_European_Countries_pdf/20077691

المؤلفون: Vasileios Kourafalos, Eleonora Allocati, Luka Voncina, Brian Godman, Arianit Jakupi, Robert Plisko, Evelien Moorkens, Kateřina Kohoutová, Nataša Grubiša, Gisbert Selke, Anita Viksna, Arnold G. Vulto, Jurij Fürst, Jaana E. Martikainen, Leona Popelková, Ileana Mardare, Patricia Vella Bonanno, Vincent Suttorp, Dorthe Bartels, Sarah Mörtenhuber, Ott Laius, Iris Hoxha, Gustaf Befrits, Isabelle Huys, Dmitry Meshkov, Gnosia Achniotou, Rannveig Einarsdóttir, Øyvind Melien, Juraj Slabý, Ieva Greičiūtė-Kuprijanov, Simon Keuerleber, Einar Magnusson, Corinne Zara, Admir Malaj, Robert Puckett, Silvia Stockinger, Vanda Marković-Peković, Maria Dimitrova, Vera Vlahović Palčevski, Konstantin Tachkov, Tanja Novakovic, Roisin Adams, Roberta Joppi

المساهمون: Erasmus MC other, Pharmacy

المصدر: Frontiers in Pharmacology, Vol 11 (2021)
Frontiers in Pharmacology, 11:591134. Frontiers Media S.A.
Frontiers in Pharmacology
Volume 11

مصطلحات موضوعية: Leverage (finance), adalimumab, prices, biosimilars, Europe, Humira, competition, health policy, BIOMEDICINA I ZDRAVSTVO. Kliničke medicinske znanosti. Klinička farmakologija s toksikologijom, RS, Competition (economics), adalimumab, Adalimumab, medicine, National Policy, Pharmacology (medical), biosimilars, Humira, Reimbursement, Health policy, Pharmacology, Public economics, lcsh:RM1-950, Biosimilar, health policy, BIOMEDICINE AND HEALTHCARE. Clinical Medical Sciences. Clinical Pharmacology and Toxicology, Product (business), Europe, lcsh:Therapeutics. Pharmacology, Business, competition, prices, medicine.drug

وصف الملف: Electronic-eCollection; application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::faa4da2fb244fd6ae5a4663168b042ca
https://www.frontiersin.org/articles/10.3389/fphar.2020.591134/full

المؤلفون: Ruaraidh Hill, Christian Hierländer, Carolina Zampirolli Dias, Tomasz Bochenek, Ott Laius, Lars L. Gustafsson, Tracey-Lea Laba, Arianit Jakupi, Øyvind Melien, Wija Oortwijn, Luka Voncina, Durhane Wong-Rieger, Caridad Pontes, Jf Hans Piepenbrink, Magdalene Wladysiuk, Guenka Petrova, Patricia Vella Bonanno, Corinne Zara, Robert Sauermann, Steven Simoens, Olayinka O Ogunleye, Amanj Kurdi, Wouter Hamelinck, Wania Cristina Silva, Dzintars Gotham, Seung Jin Bae, Johanna C Meyer, Roberta Joppi, Janet Wale, Admir Malaj, John Yfantopoulos, Gisbert Selke, Angela Timoney, Brian Godman, Vincent de Valk, Andrew Hill, Merce Obach Cortadellas, D Tomek, Hye-Young Kwon, Irene Langner, Jurij Fürst, Iva Selke Krulichová, Antony P. Martin, Jolanta Gulbinovič, Iris Hoxha, Eleonora Allocati, Stuart McTaggart, Ieva Greiciute-Kuprijanov, Vanda Marković-Peković, Ileana Mardare

المساهمون: Godman, Brian, Hill, Andrew, Simoens, Steven, Selke, Gisbert, Laba, Tracey-Lea, Hill, Ruaraidh

المصدر: Expert review of pharmacoeconomics and outcomes research, Abingdon : Taylor and Francis Ltd., 2021, vol. 21, iss. 4, p. 527-540
Expert Review of Pharmacoeconomics and Outcomes Research, 21, 527-540
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH
Expert Review of Pharmacoeconomics and Outcomes Research, 21, 4, pp. 527-540
Expert review of pharmacoeconomics & outcomes research

مصطلحات موضوعية: Transparency (market), Amortization (business), Medical care -- Cost control, Alternative pricing approaches, cancer medicines, europe, managed entry agreements, minimum effectiveness criteria, multicriteria decision analyses, payers, tiered pricing approaches, transparent pricing approaches, 0302 clinical medicine, Neoplasms, Health care, Pharmacology (medical), Confidentiality, 030212 general & internal medicine, Pharmacology & Pharmacy, Reimbursement, health care economics and organizations, Public economics, 030503 health policy & services, Health Policy, General Medicine, Europe, Models, Economic, Value (economics), Health Policy & Services, Costs and Cost Analysis, 0305 other medical science, Life Sciences & Biomedicine, Scrutiny, Cancer -- Treatment -- Europe, Antineoplastic Agents, Medical care -- Cost control -- Europe, Drug Costs, Patents as Topic, Reimbursement Mechanisms, 03 medical and health sciences, Drug Development, Humans, Drugs -- Law and legislation -- Decision making, 1115 Pharmacology and Pharmaceutical Sciences, 1117 Public Health and Health Services, 1402 Applied Economics, Science & Technology, business.industry, lnfectious Diseases and Global Health Radboud Institute for Health Sciences [Radboudumc 4], Health Care Sciences & Services, Sustainability, Business, RA, Delivery of Health Care

وصف الملف: application/pdf; Print-Electronic

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3dfe77330e4296c7333cde6b78e19b86
https://repository.vu.lt/VU:ELABAPDB88291411&prefLang=en_US

المؤلفون: Evelien, Moorkens, Brian, Godman, Isabelle, Huys, Iris, Hoxha, Admir, Malaj, Simon, Keuerleber, Silvia, Stockinger, Sarah, Mörtenhuber, Maria, Dimitrova, Konstantin, Tachkov, Luka, Vončina, Vera Vlahović, Palčevski, Gnosia, Achniotou, Juraj, Slabý, Leona, Popelková, Kateřina, Kohoutová, Dorthe, Bartels, Ott, Laius, Jaana E, Martikainen, Gisbert W, Selke, Vasileios, Kourafalos, Einar, Magnússon, Rannveig, Einarsdóttir, Roisín, Adams, Roberta, Joppi, Eleonora, Allocati, Arianit, Jakupi, Anita, Viksna, Ieva, Greičiūtė-Kuprijanov, Patricia, Vella Bonanno, Vincent, Suttorp, Øyvind, Melien, Robert, Plisko, Ileana, Mardare, Dmitry, Meshkov, Tanja, Novakovic, Jurij, Fürst, Corinne, Zara, Vanda, Marković-Peković, Nataša, Grubiša, Gustaf, Befrits, Robert, Puckett, Arnold G, Vulto

المصدر: Frontiers in Pharmacology

مصطلحات موضوعية: Pharmacology, Europe, adalimumab, biosimilars, Humira, health policy, competition, prices, Original Research

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid________::4d8152979b218c4c2a189561dc041fcd
https://pubmed.ncbi.nlm.nih.gov/33519450

المؤلفون: Evelien Moorkens, Brian Godman, Isabelle Huys, Iris Hoxha, Admir Malaj, Simon Keuerleber, Silvia Stockinger, Sarah Mörtenhuber, Maria Dimitrova, Konstantin Tachkov, Luka Vončina, Vera Vlahović Palčevski, Gnosia Achniotou, Juraj Slabý, Leona Popelková, Kateřina Kohoutová, Dorthe Bartels, Ott Laius, Jaana E. Martikainen, Gisbert W. Selke, Vasileios Kourafalos, Einar Magnússon, Rannveig Einarsdóttir, Roisín Adams, Roberta Joppi, Eleonora Allocati, Arianit Jakupi, Anita Viksna, Ieva Greičiūtė-Kuprijanov, Patricia Vella Bonanno, Vincent Suttorp, Øyvind Melien, Robert Plisko, Ileana Mardare, Dmitry Meshkov, Tanja Novakovic, Jurij Fürst, Corinne Zara, Vanda Marković-Peković, Nataša Grubiša, Gustaf Befrits, Robert Puckett, Arnold G. Vulto

مصطلحات موضوعية: Pharmacology, Basic Pharmacology, Clinical Pharmacology and Therapeutics, Clinical Pharmacy and Pharmacy Practice, Pharmaceutical Sciences, Pharmacogenomics, Toxicology (incl. Clinical Toxicology), Pharmacology and Pharmaceutical Sciences not elsewhere classified, adalimumab, prices, biosimilars, Europe, Humira, competition, health policy

Relation: https://figshare.com/articles/dataset/datasheet1_The_Expiry_of_Humira_Market_Exclusivity_and_the_Entry_of_Adalimumab_Biosimilars_in_Europe_An_Overview_of_Pricing_and_National_Policy_Measures_pdf/13567664

الاتاحة: https://doi.org/10.3389/fphar.2020.591134.s001
https://figshare.com/articles/dataset/datasheet1_The_Expiry_of_Humira_Market_Exclusivity_and_the_Entry_of_Adalimumab_Biosimilars_in_Europe_An_Overview_of_Pricing_and_National_Policy_Measures_pdf/13567664

المؤلفون: Alric Ruether, Jacques Demotes, Øyvind Melien, Frank Hulstaert

المصدر: International journal of technology assessment in health care. 36(2)

مصطلحات موضوعية: medicine.medical_specialty, Technology Assessment, Biomedical, Cost-Benefit Analysis, Decision Making, 030204 cardiovascular system & hematology, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, Inventions, Order (exchange), law, Health care, medicine, Humans, 030212 general & internal medicine, Marketing, Cooperative Behavior, health care economics and organizations, Randomized Controlled Trials as Topic, Health Care Rationing, Public Sector, business.industry, Health Policy, Public health, Financing, Organized, Health technology, Private sector, Product (business), Europe, Interinstitutional Relations, Private healthcare, Private Sector, Business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b53025d13c4aa0e3fc1e0e5b6494d447
https://pubmed.ncbi.nlm.nih.gov/31948497

المؤلفون: Markus Siebert, Janneke P.C. Grutters, Kari J. Kværner, Øyvind Melien, Marcia Tummers, Laura Sampietro-Colom, Murray Krahn, Payam Abrishami, Dominique Hamerlijnck

المساهمون: Erasmus School of Health Policy & Management

المصدر: International Journal of Technology Assessment in Health Care. Cambridge University Press
International Journal of Technology Assessment in Health Care, 36, 5, pp. 481-485
International Journal of Technology Assessment in Health Care, 36, 481-485
International Journal of Technology Assessment in Health Care

مصطلحات موضوعية: Value (ethics), Process management, Technology Assessment, Biomedical, Process (engineering), 030503 health policy & services, Health Policy, Best practice, Policy maker, Innovation process, Health technology, Variety (cybernetics), Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18], 03 medical and health sciences, 0302 clinical medicine, Stakeholder Participation, Urological cancers Radboud Institute for Health Sciences [Radboudumc 15], Assessment methods, 030212 general & internal medicine, Business, Diffusion of Innovation, 0305 other medical science, Policy Making

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aebc044da4a176cfb2bc26047b90abdb
https://pure.eur.nl/en/publications/d569a617-cbf1-4a47-bcee-5aa28298fbf0

المؤلفون: Dan Kibuule, Øyvind Melien, Krijn Schiffers, Alec Morton, Brian Godman, Joseph O Fadare, Babar Khan, Alexander E. Finlayson, Shazhad Hussein, Ahmed Salem, Amanj Kurdi, Marija Kalaba, Tomasz Bochenek, Christoph Baumgärtel, Luka Voncina, Azmi Hassali, Renata Crm Nascimento, Hye-Young Kwon, Axel Leporowski, Ilse Truter

مصطلحات موضوعية: Class (computer programming), RM, Public economics, business.industry, media_common.quotation_subject, HB, Stakeholder, Context (language use), 030204 cardiovascular system & hematology, Appropriate use, 03 medical and health sciences, 0302 clinical medicine, Health care, Quality (business), 030212 general & internal medicine, Magic bullet, Enforcement, business, media_common

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d488cd840c228b1f23dfeb6ebe3e036d
https://ruj.uj.edu.pl/xmlui/handle/item/94705

المؤلفون: Øyvind Melien, Oddgeir L. Holmen, Solfrid Romundstad

المصدر: American Journal of Hypertension. 23:1121-1127

مصطلحات موضوعية: Male, medicine.medical_specialty, Genotype, Population, Blood Pressure, Disease, Diabetes mellitus, Internal medicine, Epidemiology, Internal Medicine, medicine, Humans, education, Alleles, Antihypertensive Agents, Genetic Association Studies, Aged, education.field_of_study, Polymorphism, Genetic, Norway, Reverse Transcriptase Polymerase Chain Reaction, business.industry, DNA, Odds ratio, Middle Aged, medicine.disease, Heterotrimeric GTP-Binding Proteins, Logistic Models, Endocrinology, Blood pressure, Cardiovascular Diseases, Hypertension, Female, business, GNB3

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8e667fdac20a69150d92241b70a1739
https://doi.org/10.1038/ajh.2010.121

المؤلفون: Solfrid Romundstad, Jostein Holmen, Øyvind Melien

المصدر: American Journal of Hypertension. 23:1114-1120

مصطلحات موضوعية: Male, medicine.medical_specialty, Genotype, Blood Pressure, Gastroenterology, Body Mass Index, chemistry.chemical_compound, Risk Factors, Internal medicine, Odds Ratio, Internal Medicine, medicine, Albuminuria, Humans, Endothelial dysfunction, Alleles, Genetic Association Studies, Aged, Sex Characteristics, Creatinine, Polymorphism, Genetic, Proteinuria, Norway, Reverse Transcriptase Polymerase Chain Reaction, business.industry, DNA, Odds ratio, Middle Aged, medicine.disease, Heterotrimeric GTP-Binding Proteins, Logistic Models, Endocrinology, chemistry, Cardiovascular Diseases, Hypertension, Female, Microalbuminuria, medicine.symptom, business, Body mass index

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::146e42692760c947c9aaaeeef181184a
https://doi.org/10.1038/ajh.2010.131

المؤلفون: Wolfgang Ballensiefen, Lada Leyens, Øyvind Melien, Etienne Richer, Angela Brand

المساهمون: Genetica & Celbiologie, RS: GROW - Developmental Biology, RS: GROW - R4 - Reproductive and Perinatal Medicine, Promovendi ODB, Institute for Public Health Genomics

المصدر: Public Health Genomics, 18(5), 249-259. Karger

مصطلحات موضوعية: Biomedical Research, Cost-Benefit Analysis, Drug development, Pharmacology, Risk Assessment, Health Services Accessibility, Conditional approval, European Medicines Agency, Drug Discovery, Medicine, media_common.cataloged_instance, Humans, European Union, European union, Health technology assessment, Precision Medicine, Drug Approval, Genetics (clinical), Societies, Medical, media_common, Marketing of Health Services, Clinical Trials as Topic, Accelerated approval, Cost–benefit analysis, Scope (project management), business.industry, United States Food and Drug Administration, Public Health, Environmental and Occupational Health, Food and Drug Administration, Environmental exposure, Public relations, Precision medicine, Personalized medicine, United States, Clinical trial, Europe, Early patient access, business, Regulation, Forecasting

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f33be61ba9abdc9ef505ea74e370976b
https://pubmed.ncbi.nlm.nih.gov/26316202

المؤلفون: Ellen Johanne Johansen, Øyvind Melien, Dagny Sandnes, Thoralf Christoffersen

المصدر: Journal of Cellular Physiology. 184:27-36

مصطلحات موضوعية: Male, MAPK/ERK pathway, medicine.medical_specialty, Vasopressins, Physiology, Clinical Biochemistry, Inositol 1,4,5-Trisphosphate, GTP-Binding Protein alpha Subunits, Gi-Go, Biology, Dinoprost, Pertussis toxin, Norepinephrine, Phosphoinositide Phospholipase C, Receptors, Adrenergic, alpha-1, Internal medicine, Phospholipase D, medicine, Animals, Virulence Factors, Bordetella, Rats, Wistar, Receptor, Calcimycin, Cells, Cultured, Protein kinase C, G protein-coupled receptor, Mitogen-Activated Protein Kinase 1, Mitogen-Activated Protein Kinase 3, Epidermal Growth Factor, Phospholipase C, Angiotensin II, Phosphatidylinositol Diacylglycerol-Lyase, Cell Biology, Rats, Cell biology, Enzyme Activation, ErbB Receptors, Endocrinology, Liver, Pertussis Toxin, Type C Phospholipases, Thapsigargin, Mitogen-Activated Protein Kinases, Signal transduction, Cell Division

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b303d036998c73e12374d314e6bf9d70
https://doi.org/10.1002/(sici)1097-4652(200007)184:1<27::aid-jcp3>3.0.co;2-q